Skip to main content
. 2017 Oct 2;175(2):246–261. doi: 10.1111/bph.13983

Figure 4.

Figure 4

Olaparib does not protect cardiac myoblasts against prolonged, low‐level oxidative stress. (A) Experimental design. Reduction of MTT (B) and release of LDH (C) in H9c2 cells treated with 0.05 U·mL−1 GOx in the absence or presence of 10 μM olaparib (olap). (D) Western blot analysis of PARylation and PARP1 (* indicates a non‐specific band). Data shown are means ± SEM. n = 5 per group.